Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

AlzeCure Pharma AB (publ) (AC6.F)

0.1755
-0.0015
(-0.85%)
At close: May 2 at 8:12:33 AM GMT+2
Currency in SEK All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
36,144
36,144
38,262
56,569
78,143
Operating Income
-36,144
-36,144
-38,262
-56,569
-78,143
Net Non Operating Interest Income Expense
910
910
1,095
203
145
Pretax Income
-35,234
-35,234
-37,167
-56,239
-77,781
Net Income Common Stockholders
-35,234
-35,234
-37,167
-56,239
-77,781
Diluted NI Available to Com Stockholders
-35,234
-35,234
-37,167
-56,239
-77,781
Basic EPS
-0.44
-0.46
-0.60
-1.05
-1.83
Diluted EPS
-0.44
-0.46
-0.60
-1.05
-1.83
Basic Average Shares
78,573.9810
77,151.5500
62,087.0120
53,822.1940
42,616.3570
Diluted Average Shares
78,573.9810
77,151.5500
62,087.0120
54,222.7900
43,079.0170
Total Operating Income as Reported
-36,144
-36,144
-38,262
-56,442
-77,926
Total Expenses
36,144
36,144
38,262
56,569
78,143
Net Income from Continuing & Discontinued Operation
-35,234
-35,234
-37,167
-56,239
-77,781
Normalized Income
-35,234
-35,234
-37,167
-56,239
-77,781
Interest Income
929
929
1,102
207
146
Interest Expense
19
19
7
4
1
Net Interest Income
910
910
1,095
203
145
EBIT
-35,215
-35,215
-37,160
-56,235
-77,780
EBITDA
-34,922
-34,922
-36,684
-55,665
-77,204
Reconciled Depreciation
293
293
476
570
576
Net Income from Continuing Operation Net Minority Interest
-35,234
-35,234
-37,167
-56,239
-77,781
Normalized EBITDA
-34,922
-34,922
-36,684
-55,665
-77,204
12/31/2021 - 2/21/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers